Obstetrics & Gynecology

Skip Navigation LinksHome > June 2013 - Volume 121 - Issue 6 > Adherence to Treatment Guidelines for Ovarian Cancer as a Me...
Obstetrics & Gynecology:
doi: 10.1097/AOG.0b013e3182922a17
Original Research

Adherence to Treatment Guidelines for Ovarian Cancer as a Measure of Quality Care

Bristow, Robert E. MD, MBA; Chang, Jenny MPH; Ziogas, Argyrios; Anton-Culver, Hoda PhD

Collapse Box

Abstract

OBJECTIVES: To validate National Comprehensive Cancer Network ovarian cancer guideline adherence as a quality process measure associated with improved survival, and to identify structural health care characteristics predictive of adherence to National Comprehensive Cancer Network guideline care.

METHODS: Consecutive patients with epithelial ovarian cancer diagnosed between 1 January 1999 and 31 December 2006 were identified from the California Cancer Registry. Adherence to National Comprehensive Cancer Network guideline care was defined by stage-appropriate surgical procedures and recommended chemotherapy. Multivariable logistic regression models were used to identify characteristics predictive of National Comprehensive Cancer Network guideline adherence and ovarian cancer–specific survival.

RESULTS: A total of 13,321 patients were identified. Overall, 37.2% of patients received National Comprehensive Cancer Network guideline–adherent care. Guideline-adherent care was associated with high-volume hospitals (20 or more cases per year; 50.8% compared with 34.1%; P<.001) and high-volume physicians (10 or more cases per year; 47.6% compared with 34.5%; P<.001). After controlling for other factors, both low-volume hospitals (odds ratio [OR] 1.83, 95% confidence interval [CI] 1.66–2.01) and low-volume physicians (OR 1.19, 95% CI 1.07–1.32) were independently associated with deviation from National Comprehensive Cancer Network guidelines. On multivariable survival analysis, nonadherence to National Comprehensive Cancer Network guideline care was associated with decreased disease-specific survival (hazard ratio [HR] 1.33, 95% CI 1.26–1.41). Both low-volume hospitals (HR 1.08, 95% CI 1.01–1.16) and low-volume physicians (HR 1.18, 95% CI 1.09–1.28) were associated with decreased disease-specific survival after adjusting for National Comprehensive Cancer Network guideline–adherent care.

CONCLUSIONS: Adherence to National Comprehensive Cancer Network guidelines for treatment of ovarian cancer is correlated with improved survival and may be a useful process measure of quality cancer care. Ovarian cancer case volume correlates with a higher likelihood of recommended care and improved survival and may be a useful structural quality measure. Increased efforts to concentrate ovarian cancer care are warranted.

LEVEL OF EVIDENCE: II

© 2013 The American College of Obstetricians and Gynecologists

Login

 

Looking for ABOG articles? Visit our ABOG MOC II collection. The selected Green Journal articles are free through the end of the calendar year.

ACOG MEMBER SUBSCRIPTION ACCESS

If you are an ACOG Fellow and have not logged in or registered to Obstetrics & Gynecology, please follow these step-by-step instructions to access journal content with your member subscription.

Article Tools

Share

Article Level Metrics